|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 627.00 KRW | -5.00% |
|
-19.10% | -79.97% |
| 04-07 | ABION Announces Preclinical Data Showing IFN-? Antibody Fusion Abn202 Outperforms Trop2-Targeting ADCs | CI |
| 25-04-04 | Abion To Divest 5.9 Billion Won Worth Of Shares In Vivozon Inc | RE |
Company Valuation: Abion Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 85,498 | 273,810 | 126,828 | 163,611 | 200,458 | 282,017 |
| Change | - | 220.25% | -53.68% | 29% | 22.52% | 40.69% |
| Enterprise Value (EV) 1 | 102,397 | 240,792 | 114,431 | 167,986 | 214,505 | 253,683 |
| Change | - | 135.15% | -52.48% | 46.8% | 27.69% | 18.26% |
| P/E | -8.16x | -3.89x | -6.36x | -5.53x | -4.02x | -7.21x |
| PBR | -4.28x | 8.53x | 8.4x | 18.6x | 7.37x | 4.12x |
| PEG | - | -0x | 0.1x | -0.1x | -0.2x | 0.1x |
| Capitalization / Revenue | 42.9x | 167x | 50.6x | 128x | 264x | 320x |
| EV / Revenue | 51.4x | 147x | 45.7x | 132x | 282x | 288x |
| EV / EBITDA | -9.86x | -23.7x | -4.64x | -5.49x | -6.38x | -13.6x |
| EV / EBIT | -9.36x | -22.6x | -4.55x | -5.39x | -6.28x | -13.1x |
| EV / FCF | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -468.9 | -2,085 | -588.2 | -846.8 | -1,000 | -434.4 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 1,994 | 1,638 | 2,507 | 1,274 | 759.7 | 880.1 |
| EBITDA 1 | -10,386 | -10,170 | -24,670 | -30,613 | -33,634 | -18,706 |
| EBIT 1 | -10,942 | -10,672 | -25,167 | -31,161 | -34,164 | -19,372 |
| Net income 1 | -10,476 | -54,259 | -19,925 | -29,211 | -43,381 | -29,063 |
| Net Debt 1 | 16,899 | -33,018 | -12,397 | 4,375 | 14,047 | -28,334 |
| Reference price 2 | 3,827.78 | 8,111.11 | 3,738.89 | 4,683.33 | 4,022.22 | 3,130.00 |
| Nbr of stocks (in thousands) | 22,336 | 33,757 | 33,921 | 34,935 | 49,838 | 90,101 |
| Announcement Date | 3/11/22 | 3/11/22 | 3/21/23 | 3/21/24 | 3/20/25 | 3/13/26 |
1KRW in Million2KRW
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 39.82M | |
| 20.06x | 6.16x | 13.43x | 1.6% | 53.54B | |
| 32.54x | 8.23x | 25.52x | 0.06% | 54.18B | |
| -41.84x | 13.68x | -39.9x | -.--% | 23.66B | |
| -17.97x | 4.21x | -7.37x | -.--% | 22.78B | |
| 24.64x | 4.81x | 12.68x | -.--% | 19.54B | |
| 25.1x | 4.86x | 15.83x | -.--% | 17.82B | |
| 48x | 19.5x | 50.21x | 0.08% | 16.01B | |
| -526.19x | 37.05x | -4130.99x | -.--% | 15.37B | |
| 17.61x | 5.12x | 11.91x | -.--% | 14.09B | |
| Average | -46.45x | 11.51x | -449.85x | 0.19% | 23.7B | |
| Weighted average by Cap. | -19.85x | 9.83x | -257.40x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A203400 Stock
- Valuation Abion Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
